Prothena Corp Public (PRTA) Current Leases (2019 - 2026)
Prothena Corp Public's (PRTA) quarterly Current Leases came in at $2.9 million in Q1 2026, up 10.08% year-on-year from $2.6 million in Q1 2025, and little changed quarter-over-quarter from $2.9 million in Q4 2025.
Prothena Corp Public (PRTA) Current Leases (2019 - 2026) Analysis & Trends
Prothena Corp Public's Current Leases history runs 8 years deep, the most recent figure standing at $2.9 million for Q1 2026.
- On a quarterly basis, Current Leases rose 10.08% year-over-year to $2.9 million in Q1 2026; TTM through Mar 2026 was $2.9 million, a 10.08% increase from a year earlier, with the FY2025 full-year figure at $2.9 million, up 10.57% from the prior year.
- Current Leases steadied at $2.9 million in Q1 2026 per PRTA's latest filing, from $2.9 million in the prior quarter.
- Across five years, Current Leases topped out at $6.5 million in Q4 2022 and bottomed at $1.1 million in Q4 2023.
- The 5-year median for Current Leases is $2.9 million (2025), against an average of $3.6 million.
- Across the five-year window, Current Leases slumped 82.79% in 2023 and surged 134.29% in 2024, its largest moves.
- Year by year, Current Leases stood at $6.5 million in 2022, then slumped by 82.79% to $1.1 million in 2023, then jumped by 134.29% to $2.6 million in 2024, then increased by 10.57% to $2.9 million in 2025, then grew by 0.24% to $2.9 million in 2026.
- Per Business Quant, the three latest PRTA Current Leases figures stand at $2.9 million (Q1 2026), $2.9 million (Q4 2025), and $2.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.61 Mn |
| 10 | Prothena Corp Public | 467.80 Mn | 138.33 Mn | - | 2.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.89 Mn |
| Dec 31, 2025 | 2.89 Mn |
| Sep 30, 2025 | 2.88 Mn |
| Jun 30, 2025 | 2.85 Mn |
| Mar 31, 2025 | 2.63 Mn |
| Dec 31, 2024 | 2.61 Mn |
| Sep 30, 2024 | 2.61 Mn |
| Jun 30, 2024 | 2.58 Mn |
| Mar 31, 2024 | 2.37 Mn |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 1.82 Mn |
| Jun 30, 2023 | 3.45 Mn |
| Mar 31, 2023 | 4.89 Mn |
| Dec 31, 2022 | 6.47 Mn |
| Sep 30, 2022 | 6.39 Mn |
| Jun 30, 2022 | 6.30 Mn |
| Mar 31, 2022 | 6.05 Mn |
| Dec 31, 2021 | 5.94 Mn |
| Sep 30, 2021 | 5.83 Mn |
| Jun 30, 2021 | 5.72 Mn |